(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.01%) $82.62
(0.84%) $2.05
(-0.57%) $2 344.30
(-1.14%) $27.35
(-0.29%) $958.70
(0.08%) $0.933
(0.14%) $11.00
(0.01%) $0.796
(1.56%) $93.31
-0.85% INR 1 229.30
Live Chart Being Loaded With Signals
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents...
Stats | |
---|---|
Dagens volum | 8 984.00 |
Gjennomsnittsvolum | 31 095.00 |
Markedsverdi | 28.76B |
EPS | INR3.43 ( 2023-11-02 ) |
Last Dividend | INR2.00 ( 2023-09-08 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 73.43 |
ATR14 | INR1.935 (0.16%) |
Volum Korrelasjon
Tatva Chintan Pharma Chem Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Tatva Chintan Pharma Chem Korrelasjon - Valuta/Råvare
Tatva Chintan Pharma Chem Økonomi
Annual | 2022 |
Omsetning: | INR4.24B |
Bruttogevinst: | INR1.98B (46.63 %) |
EPS: | INR20.52 |
FY | 2022 |
Omsetning: | INR4.24B |
Bruttogevinst: | INR1.98B (46.63 %) |
EPS: | INR20.52 |
FY | 2022 |
Omsetning: | INR4.31B |
Bruttogevinst: | INR2.24B (51.85 %) |
EPS: | INR44.59 |
FY | 2021 |
Omsetning: | INR2.97B |
Bruttogevinst: | INR1.41B (47.63 %) |
EPS: | INR26.02 |
Financial Reports:
No articles found.
Tatva Chintan Pharma Chem Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR2.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR2.00 | 2022-09-08 |
Last Dividend | INR2.00 | 2023-09-08 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | INR4.00 | -- |
Avg. Dividend % Per Year | 0.04% | -- |
Score | 1.37 | -- |
Div. Sustainability Score | 2.47 | |
Div.Growth Potential Score | 3.05 | |
Div. Directional Score | 2.76 | -- |
Year | Amount | Yield |
---|---|---|
2022 | INR2.00 | 0.08% |
2023 | INR2.00 | 0.09% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PUNJABCHEM.NS | Dividend Junior | 2023-07-27 | Sporadic | 18 | 0.16% | |
KENNAMET.NS | Dividend Knight | 2023-05-25 | Annually | 4 | 0.76% | |
ELECTCAST.NS | Dividend Junior | 2023-09-04 | Annually | 23 | 1.51% | |
AHLUCONT.NS | Dividend Junior | 2023-09-22 | Sporadic | 15 | 0.04% | |
SUNPHARMA.NS | Dividend Junior | 2023-07-28 | Semi-Annually | 29 | 0.77% | |
NAVA.NS | Dividend Knight | 2023-07-24 | Annually | 23 | 2.35% | |
HONAUT.NS | Dividend Junior | 2023-08-03 | Annually | 21 | 0.15% | |
CARBORUNIV.NS | Dividend Junior | 2023-07-25 | Semi-Annually | 23 | 0.33% | |
ROHLTD.NS | Dividend Junior | 2023-09-15 | Sporadic | 19 | 0.20% | |
LAURUSLABS.NS | Dividend Knight | 2023-05-10 | Semi-Annually | 8 | 0.35% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0898 | 1.500 | 8.20 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0607 | 1.500 | -0.437 | -0.655 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 5.15 | 1.000 | 9.20 | 9.20 | [3 - 30] |
operatingCashFlowPerShareTTM | 18.73 | 2.00 | 3.76 | 7.52 | [0 - 30] |
freeCashFlowPerShareTTM | 18.73 | 2.00 | 0.637 | 1.273 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.505 | 1.000 | 4.91 | 4.91 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.117 | 1.000 | 9.66 | 9.66 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.47 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 76.82 | 1.000 | 2.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0607 | 2.50 | -0.281 | -0.655 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 18.73 | 2.00 | 3.76 | 1.273 | [0 - 30] |
dividendYielPercentageTTM | 0.162 | 1.500 | 5.96 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 18.73 | 2.00 | 3.76 | 7.52 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.104 | 1.000 | 9.89 | 0 | [0.1 - 0.5] |
Total Score | 3.05 |
Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.